We're developing an affordable, wearable imaging system that can continuously monitor blood pressure and detect abnormalities in micro-vessels. This is crucial for patients at risk of hypertension. Existing blood pressure devices are expensive, inaccurate, and have limited sensing capabilities. Our technology, which utilizes multispectral tonoarteriography (MSTAG) and lenseless camera technologies, has the potential to revolutionize blood pressure monitoring. We anticipate that it will be widely applied for intelligent health monitoring across various age groups and in out-of-hospital emergency situations. With the global market for BP devices valued at 130 billion USD, we aim to provide a more accessible and effective solution.
Miss Liu Zijun* (PhD student, Department of Biomedical Engineering, City University of Hong Kong)
Miss Li Hongjin (PhD student Department of Biomedical Engineering, City University of Hong Kong)
Mr Zhou Rushuang (PhD student, Department of Biomedical Engineering, City University of Hong Kong)
Mr Atif Hassan (PhD student, Department of Biomedical Engineering, City University of Hong Kong)
* Person-in-charge
(Info based on the team's application form)
- CityU HK Tech 300 Seed Fund (2023)
